BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9893984)

  • 1. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
    Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
    Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
    Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
    Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
    Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
    Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin receptor binding determinants in the agouti protein.
    Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
    Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors.
    Fong TM; Mao C; MacNeil T; Kalyani R; Smith T; Weinberg D; Tota MR; Van der Ploeg LH
    Biochem Biophys Res Commun; 1997 Aug; 237(3):629-31. PubMed ID: 9299416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
    Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
    J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in the structure-activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski AM; Joseph CG; Haskell-Luevano C
    Med Res Rev; 2005 Sep; 25(5):545-56. PubMed ID: 16044415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins.
    Li YZ; Davidowa H
    J Neurosci Res; 2004 Aug; 77(4):596-602. PubMed ID: 15264229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
    Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system.
    Hanada R; Nakazato M; Matsukura S; Murakami N; Yoshimatsu H; Sakata T
    Biochem Biophys Res Commun; 2000 Feb; 268(1):88-91. PubMed ID: 10652218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of ligand binding to the human melanocortin-4 receptor.
    Yang YK; Fong TM; Dickinson CJ; Mao C; Li JY; Tota MR; Mosley R; Van Der Ploeg LH; Gantz I
    Biochemistry; 2000 Dec; 39(48):14900-11. PubMed ID: 11101306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
    Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
    Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.